AE Wealth Management’s ARK Genomic Revolution ETF ARKG Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $1.92K | Sell |
79
-23
| -23% | -$560 | ﹤0.01% | 2048 |
|
2025
Q1 | $2.12K | Buy |
102
+25
| +32% | +$519 | ﹤0.01% | 2028 |
|
2024
Q4 | $1.81K | Buy |
+77
| New | +$1.81K | ﹤0.01% | 2005 |
|
2024
Q1 | – | Sell |
-17,271
| Closed | -$502K | – | 1191 |
|
2023
Q4 | $502K | Sell |
17,271
-776
| -4% | -$22.6K | ﹤0.01% | 1432 |
|
2023
Q3 | $503K | Sell |
18,047
-403
| -2% | -$11.2K | ﹤0.01% | 1378 |
|
2023
Q2 | $629K | Sell |
18,450
-2,905
| -14% | -$99K | ﹤0.01% | 1268 |
|
2023
Q1 | $642K | Buy |
21,355
+2,653
| +14% | +$79.8K | ﹤0.01% | 1231 |
|
2022
Q4 | $528K | Sell |
18,702
-4,158
| -18% | -$117K | ﹤0.01% | 1287 |
|
2022
Q3 | $751K | Buy |
22,860
+284
| +1% | +$9.33K | 0.01% | 1058 |
|
2022
Q2 | $711K | Sell |
22,576
-3,800
| -14% | -$120K | 0.01% | 1015 |
|
2022
Q1 | $1.21M | Sell |
26,376
-36,422
| -58% | -$1.67M | 0.01% | 856 |
|
2021
Q4 | $3.85M | Sell |
62,798
-15,691
| -20% | -$961K | 0.03% | 493 |
|
2021
Q3 | $5.87M | Sell |
78,489
-15,467
| -16% | -$1.16M | 0.05% | 342 |
|
2021
Q2 | $8.69M | Sell |
93,956
-17,216
| -15% | -$1.59M | 0.08% | 243 |
|
2021
Q1 | $9.86M | Sell |
111,172
-73,888
| -40% | -$6.56M | 0.1% | 206 |
|
2020
Q4 | $17.3M | Buy |
185,060
+16,551
| +10% | +$1.54M | 0.2% | 122 |
|
2020
Q3 | $10.7M | Sell |
168,509
-33,687
| -17% | -$2.15M | 0.15% | 134 |
|
2020
Q2 | $10.5M | Buy |
+202,196
| New | +$10.5M | 0.16% | 135 |
|